Dr. Blagosklonny’s Rapamycin-Based Recommendation for Altos Labs
May 12, 2022
Mikhail Blagosklonny, M.D., Ph.D., has a recommendation for Altos Labs in his new research perspective, entitled, “Altos Labs and the quest for immortality: but can we live longer right now?” continue reading »